{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:25:43Z","timestamp":1791278743484,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,9,25]],"date-time":"2016-09-25T00:00:00Z","timestamp":1474761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Mixed cryoglobulinemic vasculitis is associated with the monoclonal expansion of pathognomonic B cells in chronic hepatitis C. Recently, treatment with B\u2010cell depletion, including rituximab, a CD20 monoclonal antibody, has been successful in achieving remission from the active disease. We investigated whether B\u2010cell depletion therapy has an impact on activation of non\u2010B cells in the periphery. Results demonstrated that B\u2010cell depletion therapy is associated with a statistically significant decline in activated T cells, from pretherapy to follow\u2010up while on rituximab therapy: CD4+ CD38+ HLA\u2010DR+ (DR+), CD8+ CD38, CD8+ CD38+ DR+, and CD8+ DR+. Birmingham Vasculitis Activity Score and cryoglobulin had a strong correlation coefficient (<jats:italic>R<\/jats:italic>) of 0.72 (<jats:italic>P<\/jats:italic>=.0005), while cryoglobulin showed moderate correlation with CD8+ DR+ (<jats:italic>R<\/jats:italic>=.61), CD3+ CD38+ DR+ (<jats:italic>R<\/jats:italic>=.57), CD3+ DR+ (<jats:italic>R<\/jats:italic>=.50), CD4+ CD38+ DR+ (<jats:italic>R<\/jats:italic>=.53), CD4+ DR+ (<jats:italic>R<\/jats:italic>=.52), and CD8+ CD38+ DR+ (<jats:italic>R<\/jats:italic>=.67). These results suggest B\u2010cell expansion has a direct and indirect effect on the pathogenesis of Hepatitis C\u2010associated mixed cryoglobulinemic vasculitis.<\/jats:p>","DOI":"10.1111\/jvh.12618","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T03:26:45Z","timestamp":1474860405000},"page":"128-131","source":"Crossref","is-referenced-by-count":6,"title":["Decline of cellular activation in non\u2010B cells after rituximab treatment in hepatitis C\u2010associated mixed cryoglobulinemia vasculitis"],"prefix":"10.1111","volume":"24","author":[{"given":"B.","family":"Emmanuel","sequence":"first","affiliation":[{"name":"Division of Clinical Care and Research Institute of Human Virology University of Maryland School of Medicine  Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sidique","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoregulation Department of Health and Human Services National Institute of Allergy and Infectious Diseases National Institutes of Health  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoregulation Department of Health and Human Services National Institute of Allergy and Infectious Diseases National Institutes of Health  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Poonia","sequence":"additional","affiliation":[{"name":"Division of Clinical Care and Research Institute of Human Virology University of Maryland School of Medicine  Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Sneller","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoregulation Department of Health and Human Services National Institute of Allergy and Infectious Diseases National Institutes of Health  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kottilil","sequence":"additional","affiliation":[{"name":"Division of Clinical Care and Research Institute of Human Virology University of Maryland School of Medicine  Baltimore MD USA"},{"name":"Laboratory of Immunoregulation Department of Health and Human Services National Institute of Allergy and Infectious Diseases National Institutes of Health  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,9,25]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/M13-1133"},{"key":"e_1_2_9_3_1","unstructured":"Centers for Disease Control and Prevention.Viral Hepatitis Surveillance United States 2014 [Internet].2014. Available from:http:\/\/www.cdc.gov\/hepatitis\/statistics\/2014surveillance\/index.htm"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.3.47"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.09.067"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0095"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7085"},{"key":"e_1_2_9_8_1","first-page":"65","article-title":"Extrahepatic manifestations of chronic HCV infection","volume":"16","author":"Galossi A","year":"2007","journal-title":"J Gastrointest Liver Dis JGLD"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666151102095708"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9510-9"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34322"},{"key":"e_1_2_9_12_1","first-page":"695","article-title":"Hepatitis C virus\u2010related mixed cryoglobulinemia","volume":"3","author":"Schamberg NJ","year":"2007","journal-title":"Gastroenterol Hepatol"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1993.tb00782.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000198002.42826.c2"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3282f1330c"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-122713"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2856"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34560"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.99"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(13)00228-6"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12618","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12618","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:01:24Z","timestamp":1695571284000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,25]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1111\/jvh.12618"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12618","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,25]]}}}